ADVANCED PHARMACOLOGY FOR PRESCRIBERS 1ST EDITION BY LUU KAYINGO COMPREHENSIVE PRACTICE QUESTION BANK WITH DETAILED RATIONALES AND STUDY GUIDE

ADVANCED PHARMACOLOGY FOR PRESCRIBERS 1ST EDITION BY LUU KAYINGO COMPREHENSIVE PRACTICE QUESTION BANK WITH DETAILED RATIONALES AND STUDY GUIDE TABLE OF CONTENTS PART I: Foundations of Pharmacology and Prescribing 1. An Introduction to Evidence-Based Clinical Practice Guidelines 2. Pharmacokinetics 3. Pharmacodynamics 4. Pharmacogenetics and Pharmacogenomics 5. Pharmacology Across the Life Span 6. Drug-Therapy Prescribing in Special Populations 7. Drug Development and Approval 8. Basics of Prescription Writing 9. Responsible Controlled-Substance Prescribing 10. Antibiotic Stewardship 11. Applied Calculations for Prescribing 12. Promoting Adherence with Pharmacotherapy PART II: System-Specific & Patient-Focused Prescribing 13. Pharmacotherapy for Ear, Nose, Oral, and Throat Conditions 14. Pharmacotherapy for Eye Conditions 15. Pharmacotherapy for Skin Conditions 16. Pharmacotherapy for Neurologic Conditions 17. Pharmacotherapy for Cardiovascular Conditions 18. Pharmacotherapy for Respiratory Conditions 19. Pharmacotherapy for Gastrointestinal Conditions and Conditions Requiring Nutritional Support 20. Pharmacotherapy for Genitourinary Conditions 21. Pharmacotherapy for Renal, Acid–Base, and Fluid and Electrolyte Disorders 22. Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions 23. Therapeutic Applications of Immunology and Vaccines 24. Pharmacotherapy for Endocrine Disorders 25. Pharmacology for Hematologic Conditions 26. Hematology/Oncology and Supportive Care for the Non- Oncologist 27. Pharmacotherapy Related to Women’s Health Conditions 28. Pharmacotherapy Related to Men’s Health Conditions CHAPTER 1: AN INTRODUCTION TO EVIDENCE-BASED CLINICAL PRACTICE GUIDELINES This chapter introduces evidence-based clinical practice guidelines (CPGs) as essential tools for safe, effective prescribing. It emphasizes the integration of best research evidence, clinical expertise, and patient values. Nurses must critically appraise CPGs, understand their development and grading systems, and apply them judiciously to individualize pharmacotherapy. The chapter also addresses barriers to CPG implementation, the importance of shared decision-making, and the ongoing responsibility to monitor for new evidence to ensure optimal patient outcomes and patient safety. 1. A nurse practitioner is evaluating a new clinical practice guideline for managing hypertension. Which action best reflects a critical appraisal of the guideline's applicability to a specific patient? A. Implementing the guideline exactly as written for all hypertensive patients B. Comparing the guideline recommendations to the patient's individual clinical profile and values C. Using the guideline only when the patient has no other comorbidities D. Following the guideline without considering patient preferences to ensure consistency Correct Answer: B Rationale: Applying CPGs requires individualization based on patient-specific factors and shared decision-making, not rigid adherence, which ensures patient-centered care and safety.